Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological…
| Price | $0.73 |
|---|---|
| Market cap | $287.41M |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| Exchange | NASDAQ |
| 52-week range | 0.63-1.72 |
| Beta | 1.37 |
Explore LAB's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.